[1] |
Kumakech E, Andersson S, Wabinga H, et al. Cervical cancer risk perceptions, sexual risk behaviors and sexually transmitted infections among Bivalent Human Papillomavirus vaccinated and non-vaccinated young women in Uganda-5 year follow up study[J]. Bmc Womens Health, 2017, 17(1): 40-51.
|
[2] |
Wolf B, Ganzer R, Stolzenburg JU, et al. Extended mesometrial resection (EMMR): surgical approach to the treatment of locally advanced cervical cancer based on the theory of ontogenetic cancer fields[J]. Gynecol Oncol, 2017, 146(2): 292-298.
|
[3] |
王艳萍, 徐静, 张丽钰, 等. 中药清毒栓对宫颈癌SiHa细胞抑制作用的影响[J]. 中国老年学杂志, 2016, 36(8): 1822-1825.
|
[4] |
陈光福, 郭远清, 伍玉甜. 南蛇藤素可抑制肿瘤坏死因子α诱导RAW264.7细胞的炎症及增殖[J]. 中国组织工程研究, 2016, 20(37): 5552-5559.
|
[5] |
钱亚云, 李文原, 赵雪煜, 等. 南蛇藤提取物靶向mTOR抑制人肝癌HepG2细胞侵袭与转移能力的研究[J]. 中草药, 2018, 49(20): 4831-4837.
|
[6] |
Bedell S, Manders D, Kehoe S, et al. The opinions and practices of providers toward the sexual issues of cervical cancer patients undergoing treatment[J]. Gynecol Oncol, 2017, 144(3): 586-591.
|
[7] |
Orang'O EO, Itsura P, Tonui P, et al. Use of palliative cisplatinum for advanced cervical cancer in a resource-poor setting: a case series from kenya[J]. J Glob Oncol, 2016, 3(5): 539-544.
|
[8] |
王海波, 顾昊, 赵雪煜, 等. 南蛇藤提取物通过调控基质金属蛋白酶组及其抑制因子抑制人胃癌SGC-7901细胞侵袭转移的研究[J]. 中草药, 2016, 47(8): 1345-1350.
|
[9] |
Zhou YQ, Li WC, Wang ML, et al. Competitive profiling of celastrol targets in human cervical cancer HeLa cells via quantitative chemical proteomics[J]. Mol Biosyst, 2016, 13(1): 83-91.
|
[10] |
Ciepliński K, Jóźwik M, Semczuk-Sikora A, et al. Expression of p53 and selected proliferative markers (Ki-67, MCM3, PCNA, and topoisomerase IIα) in borderline ovarian tumors: correlation with clinicopathological features[J]. Histol Histopathol,2018, 33(2):171-179.
|
[11] |
Wang SJ, Dong LQ, Liu H, et al. Effect of celastrol on anti-proliferation and energy metabolism in SGC-7901 cells and ECV304 cells[J]. Chin Tradit Herbal Drugs, 2016, 47(21): 3854-3860.
|
[12] |
Wang J, Yang DJ, Luo QY, et al. APG-1252-12A induces mitochondria-dependent apoptosis through inhibiting the antiapoptotic proteins Bcl-2/Bcl-xl in HL-60 cells[J]. Int J Oncol, 2017, 51(2): 563-572.
|
[13] |
Li PP, He W, Yuan PF, et al. Celastrol induces mitochondria-mediated apoptosis in hepatocellular carcinoma Bel-7402 cells[J]. Am J Chin Med, 2015, 43(1):137-148.
|
[14] |
Zhao ZT, Fan XY, Jiang LF, et al. miR-503-3p promotes epithelial-mesenchymal transition in breast cancer by directly targeting SMAD2 and E-cadherin[J]. J Genet Genomics, 2017, 44(2): 75-84.
|
[15] |
Mo DP, Yang DH, Xiao XL, et al. MiRNA-145 suppresses lung adenocarcinoma cell invasion and migration by targeting N-cadherin[J]. Biotechnol Lett, 2017, 39(5): 701-710.
|
[16] |
Labernadie A, Kato T, Brugués A, et al. A mechanically active heterotypic E-cadherin/N-cadherin adhesion enables fibroblasts to drive cancer cell invasion[J]. Nat Cell Biol, 2017, 19(3): 224-237.
|
[17] |
Wu JH, Ding MC, Mao NF, et al. Celastrol inhibits chondrosarcoma proliferation, migration and invasion through suppression CIP2A/c-MYC signaling pathway[J]. J Pharmacol Sci, 2017, 134(1): 22-28.
|
[18] |
Prue G, Lawler M, Baker P, et al. Human papillomavirus (HPV): making the case for ‘Immunisation for All’[J]. Oral Dis, 2017, 23(6): 726-730.
|
[19] |
Chen HH, Chen SP, Zheng QL, et al. Genistein promotes proliferation of Human cervical cancer cells through estrogen receptor-mediated PI3K/Akt-NF-κB pathway[J]. J Cancer, 2018, 9(2): 288-295.
|
[20] |
Yang L, Liu YQ, Wang M, et al. Celastrus orbiculatus extract triggers apoptosis and autophagy via PI3K/Akt/mTOR inhibition in human colorectal cancer cells[J]. Oncol Lett, 2016, 12(5): 3771-3778.
|
[21] |
Fu X, Wen HQ, Jing L, et al. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway[J]. Cancer Sci, 2017, 108(4): 620-631.
|
[22] |
Grinberg-Bleyer Y, Oh H, Desrichard A, et al. NF-κB c-Rel is crucial for the regulatory T cell immune checkpoint in cancer[J]. Cell, 2017, 170(6): 1096-1108.
|
[23] |
Yu XL, Wang Q, Zhou X, et al. Celastrol negatively regulates cell invasion and migration ability of human osteosarcoma via downregulation of the PI3K/Akt/NF-κB signaling pathway in vitro[J]. Oncol Lett, 2016, 12(5): 3423-3423.
|
[24] |
Tang BF, Xu D, Zhao YL, et al. Celastrol inhibits colorectal cancer cell proliferation and migration through suppression of MMP3 and MMP7 by the PI3K/AKT signaling pathway[J]. Anticancer Drugs, 2018, 29(6): 530-538.
|